Helping Therapeutic T Cells Evade One Inhibitor, Then Applying the Brakes with Another Drug
An Australian team used precise gene editing to help therapeutic T cells maintain their function in an immunosuppressive environment while retaining the possibility of drug-based control. Experiments with patient cells and mice have shown effects, but human use still requires validation.